Effects of PAR2 antagonist on inflammatory signals and tight junction expression in protease-activated canine primary epithelial keratinocytes.
Department of Veterinary Internal Medicine, College of Veterinary Medicine, Chonnam National University, Gwangju, Korea.
Ha-Jung
HJ
Kim
CRID Center, NeoPharm Co., Ltd., Daejeon, Korea.
Se Kyoo
SK
Jeong
Department of Pediatrics, Childhood Asthma Atopy Center, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
Soo-Jong
SJ
Hong
Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, FL, USA.
Kim
K
Ahrens
Department of Dermatology, College of Medicine, University of Florida, Gainesville, FL, USA.
Rosanna
R
Marsella
D000818:Animals; D016207:Cytokines / Q000378:metabolism*; D004285:Dogs; D015603:Keratinocytes / Q000378:metabolism*; D044464:Receptor, PAR-2 / Q000037:antagonists & inhibitors* / Q000378:metabolism*; D062826:Zonula Occludens-1 Protein / Q000378:metabolism*; D000094632:Thymic Stromal Lymphopoietin
D016207:Cytokines; D044464:Receptor, PAR-2; D062826:Zonula Occludens-1 Protein; D000094632:Thymic Stromal Lymphopoietin
CPEK; PAR2; PAR2 antagonist; TSLP; ZO-1